— Previews Disruptive Gene Pools Product that Includes up to 180,000 Genes for Drug Discovery, Protein Screening and More, at $0.04 per Base Pair – — Silicon-based DNA Synthesis Platform Continues to Enable Innovative Products Across Synthetic Biology, Next-Generation Sequencing, Drug Discovery and DNA Data Storage Industries — SAN FRANCISCO–Twist Bioscience Corporation (NASDAQ: TWST), a […]

Secure cloud-based platform now combines gene target exploration, custom assay configuration and data analysis with ability to conduct follow-up experiments Hilden, Germany, and Germantown, Maryland – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of its newly enhanced GeneGlobe Design & Analysis Hub, bringing next-level experiment planning, execution and follow-up to life science researchers. […]

Partnership Will Enable Physicians to Order Clinical Immunodiagnostic Testing that Can Be Performed in Local Laboratories SEATTLE, Wash. – Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced a partnership with Illumina, Inc. (Nasdaq: ILMN) to develop […]

New York City – The strategic partnership between SpaceTime Ventures and BGI Group was announced today at the World Economic Forum’s Sustainable Development Impact Summit in New York City to unleash a new Inclusive Bio-Economy in the Tropics. To-date, biologists have only decoded 0.28% of complex life on the planet. Taking advantage of a million fold […]

Created in Collaboration with Banff Consortium to Study Mechanisms of Organ Rejection   SEATTLE–Sep. 23, 2019– NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the launch of a new gene expression panel for researchers to evaluate the human immune response following organ transplantation. The new nCounter® Human Organ Transplant […]

SAN DIEGO — Illumina, Inc. (Nasdaq:ILMN) today announced the appointment of Joydeep Goswami as Senior Vice President of Corporate Development and Strategic Planning. Mr. Goswami will be responsible for driving planning, strategic partnerships and acquisitions, and will report to President and Chief Executive Officer, Francis deSouza. Joydeep Goswami, Illumina Senior Vice President of Corporate Development […]

TEMPE, Ariz.–INanoBio, a startup developing early stage disease diagnostics by combining semiconductor nanotechnology with biotechnology and machine learning, to receive up to $5.4 Million over four years as part of the Defense Advanced Research Projects Agency (DARPA) contract worth up to $27.8 Million awarded to consortium led by the Icahn School of Medicine at Mount […]

Oxford Nanopore and Caribou Biosciences, Inc. have entered into a non-exclusive license agreement under which Caribou has granted Oxford Nanopore a worldwide, non-exclusive license under foundational CRISPR-Cas9 intellectual property controlled by Caribou for nanopore sequencing. “The Cas9 technique will enable users to select and isolate the regions of the genome they are most interested in, […]

Former Google product lead Mark Rose to serve as VP of Product Management; Healthcare software development expert Raparti Swayambhu becomes VP of Software Santa Cruz, Calif. – Ontera, the leader in silicon-based nanopore diagnostics, today announced the appointments of Mark Rose as vice president of product management and Raparti Swayambhu as vice president of software. […]

PLEASANTON, Calif., – 10x Genomics (Nasdaq: TXG) today announced the closing of its initial public offering of 11,500,000 shares of its Class A common stock, which includes the exercise in full of the underwriters’ option to purchase 1,500,000 additional shares of its Class A common stock, at a public offering price of $39.00 per share. Including the option exercise, […]